Central Bank & Trust Co. Acquires New Shares in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Central Bank & Trust Co. acquired a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 423 shares of the company’s stock, valued at approximately $33,000.

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Capital Research Global Investors bought a new stake in shares of GE HealthCare Technologies in the second quarter valued at about $4,027,040,000. Vanguard Group Inc. grew its stake in GE HealthCare Technologies by 14.7% in the third quarter. Vanguard Group Inc. now owns 44,531,402 shares of the company’s stock valued at $3,029,917,000 after purchasing an additional 5,693,244 shares during the last quarter. BlackRock Inc. purchased a new position in GE HealthCare Technologies in the second quarter valued at about $2,334,660,000. State Street Corp purchased a new position in GE HealthCare Technologies in the second quarter valued at about $1,532,290,000. Finally, Geode Capital Management LLC purchased a new position in GE HealthCare Technologies in the second quarter valued at about $601,159,000. 79.18% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

GEHC has been the topic of several analyst reports. Morgan Stanley lifted their target price on GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a research note on Monday, February 12th. UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and lifted their target price for the company from $66.00 to $88.00 in a research note on Monday, February 12th. Jefferies Financial Group assumed coverage on GE HealthCare Technologies in a research note on Thursday, November 30th. They set a “hold” rating and a $80.00 price target on the stock. Mizuho boosted their price target on GE HealthCare Technologies from $94.00 to $96.00 and gave the stock a “buy” rating in a research note on Wednesday, February 7th. Finally, HSBC assumed coverage on GE HealthCare Technologies in a research note on Thursday, February 15th. They set a “buy” rating and a $100.00 price target on the stock. Five research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $88.73.

View Our Latest Analysis on GE HealthCare Technologies

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $89.41 on Monday. The business’s 50 day moving average price is $82.41 and its 200 day moving average price is $74.16. The firm has a market cap of $40.71 billion, a P/E ratio of 29.61, a P/E/G ratio of 3.08 and a beta of 0.97. GE HealthCare Technologies Inc. has a 52 week low of $62.35 and a 52 week high of $94.50. The company has a quick ratio of 0.83, a current ratio of 1.05 and a debt-to-equity ratio of 1.18.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last issued its earnings results on Tuesday, February 6th. The company reported $1.18 EPS for the quarter, beating analysts’ consensus estimates of $1.07 by $0.11. The firm had revenue of $5.20 billion for the quarter, compared to analyst estimates of $5.09 billion. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. GE HealthCare Technologies’s revenue for the quarter was up 5.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.31 earnings per share. On average, sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Company Profile

(Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

See Also

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report).

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.